Three Aussie Stocks to Watch

Whether this is just a reprieve, or the start of a more substantial recovery remains to be seen. Should the ASX200 break and post a daily close back above the broken uptrend currently at 7340ish, it would be a vote for the latter and indicate that the correction is complete, and the uptrend has resumed.

Below are three Aussie stocks worth watching:

1. Orocobre (ORE)

Orocobre is a lithium producer whose share price has benefited in recent months from a lift in lithium’s price to multi-year highs due to the global move towards decarbonisation and tight supply. Yesterday the share price of Orocobre traded to a low of $8.19, almost 20% below its $10.08 high of last week as speculative money exited the space courtesy of the Evergrande scare and following a broker downgrade. Technically this week’s pullback is viewed as part of a corrective pullback. Providing technical support $8.20/10 area holds the expectation is for a retest and break of recent highs $10.00 area.

2. IDT (IDT)

IDT is a pharmaceutical company based in Melbourne and a solid contender to manufacture a COVID-19 mRNA vaccine for the Australian government. The share price of IDT initially rallied from .17c in March of this year when IDT issued a release, noting it was assessing the viability of producing a vaccine. In late August, it announced it was in a “state of readiness to produce a COVID-19 vaccine” that propelled the shares up to .755c. IDT is one of the only pharmaceutical companies in Australia with a sterile facility ready to produce a vaccine and probably the only one with spare capacity. For this reason and given the need for vaccines to be produced locally in the years to come, IDT is a company worth a second look.

3. QANTAS (QAN)

Australia’s national airline is currently enjoying the prospect of reopening as domestic vaccination rates continue to climb. Tourism Minister Dan Tehan said today that Australians will be able to travel aboard unrestricted by no later than Christmas once the vaccination rate in their respective states hits 80%. The Qantas stock price has rallied over 30% in the past three weeks from $4.20 to a high of $5.56, in anticipation of a travel boom from pent-up demand from a nation of people who love to travel. Dips should be well supported near $5.00 looking for a test of the November 2020, $5.79 high, before the next upside target at $6.20.

Source Tradingview. The figures stated areas of September 22nd, 2021. Past performance is not a reliable indicator of future performance. This report does not contain and is not to be taken as containing any financial product advice or financial product recommendation

The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Products and services available depend on your location and the entity holding your account. Before deciding to trade forex, commodity futures, or digital assets, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to FOREX.com or GAIN Capital refer to StoneX Group Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.

Contracts for Difference (CFDs) are not available to US residents.

FOREX.com is a trading name of GAIN Capital - FOREX.com Canada Limited, 30 Independence Blvd, Suite 300 (3rd floor), Warren, NJ 07059, USA is a member of the Canadian Investment Regulatory Organization and Member of the Canadian Investor Protection Fund. GAIN Capital – FOREX.com Canada Limited is a wholly-owned subsidiary of StoneX Group Inc.

Complaints are taken very seriously at FOREX.com. You can view our complaints procedure here.

Know your advisor